Therapeutics News

Patients with chronic graft-vs.-host disease who were treated with thymosin β4 eye drops (RGN-259, 0.1%) experienced statistically significant improvements in signs and symptoms, according to a study published in Cornea.

Phacoemulsification resulted in small and moderate intraocular pressure reductions in primary open-angle glaucoma and pseudoexfoliation glaucoma patients, respectively, according to a study recently published in Ophthalmology.

Older patients, as well as other specific patient groups, were found to require more medications after laser peripheral iridotomy, researchers reported in a study recently published in the American Journal of Ophthalmology.

Eye care professionals have to address each patient's adherence individually, researchers reported in a study recently published in Ophthalmology.

To the Editor:

Oral azithromycin was preferred over doxycycline in patients with meibomian gland dysfunction, according to a study recently published in the British Journal of Ophthalmology.

Glaucoma patients who were found to use eye drops incorrectly were often prescribed more bottles of eye drops than other patients, according to a study recently published in the Journal of Glaucoma.

Glaucoma patients with a lower health literacy were reported to be less likely to express issues with side effects and eye drop administration, according to a recent study published in Optometry and Vision Science.

Representing nearly 80% of prescriptions filled in the U.S., generic medications play a large role in the lives of health care providers and patients alike.

The FDA has accepted Shire’s new drug application and granted priority review designation for lifitegrast to treat dry eye disease in adults, according to a company release.